Beijing Succeeder Technology (SHSE:688338) ROCE %: 5.45% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688338 Beijing Succeeder Technology Inc SHSE:688338
86 GF Score
Price ¥29.13
GF Value ¥30.49
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Beijing Succeeder Technology ROCE %?

Beijing Succeeder Technology SHSE:688338 -5.05% 86 ROCE % is 5.45% as of Mar. 2026. GuruFocus rates SHSE:688338 with a GF Score™ of 86/100 and a GF Value™ of ¥30.49 (Fairly Valued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Beijing Succeeder Technology's annualized ROCE % for the quarter that ended in Mar. 2026 was 5.45%.

Beijing Succeeder Technology  (SHSE:688338) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Beijing Succeeder Technology ROCE % Related Terms

Beijing Succeeder Technology ROCE % Historical Data

* Premium members only.

The historical data trend for Beijing Succeeder Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Succeeder Technology ROCE % Chart

Beijing Succeeder Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.08 8.19 8.68 7.99 6.18

Beijing Succeeder Technology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.36 5.57 7.00 6.90 5.45
SHSE:688338
86GF Score
Beijing Succeeder Technology Inc SHSE:688338
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Succeeder Technology ROCE % Calculation

Beijing Succeeder Technology's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=103.137/( ( (1748.651 - 101.38) + (1765.541 - 74.977) )/ 2 )
=103.137/( (1647.271+1690.564)/ 2 )
=103.137/1668.9175
=6.18 %

Beijing Succeeder Technology's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=92.596/( ( (1765.541 - 74.977) + (1778.095 - 68.328) )/ 2 )
=92.596/( ( 1690.564 + 1709.767 )/ 2 )
=92.596/1700.1655
=5.45 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 5.45% mean?
Beijing Succeeder Technology (SHSE:688338) has a ROCE % of 5.45% as of Mar. 2026.
Is Beijing Succeeder Technology's ROCE % too high?
Beijing Succeeder Technology's current ROCE % is 5.45%. The Medical Devices & Instruments industry median ROCE % is 2.26. Beijing Succeeder Technology's value of 5.45% is 141.2% above this industry median. Overall, Beijing Succeeder Technology has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Succeeder Technology's ROCE % compare to ABT and SYK?
Beijing Succeeder Technology's ROCE % of 5.45% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.26. Beijing Succeeder Technology's value of 5.45% is 141.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.26, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Succeeder Technology's current ROCE % of 5.45% is 141.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Succeeder Technology's current ROCE % is 5.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Succeeder Technology stock overvalued right now?
Based on GuruFocus' analysis, Beijing Succeeder Technology (SHSE:688338) is currently considered Fairly Valued. The stock's GF Value™ is ¥30.49, compared to a current price of ¥29.13 — trading 4.5% below its estimated fair value. The current ROCE % is 5.45% and 141.2% above the Medical Devices & Instruments industry median of 2.26. Beijing Succeeder Technology's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Beijing Succeeder Technology (SHSE:688338), the current ROCE % is 5.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Succeeder Technology (SHSE:688338) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Succeeder Technology stock appears to be undervalued. The current stock price of ¥29.13 is trading 4.5% below its estimated GF Value™ of ¥30.49. GuruFocus considers Beijing Succeeder Technology to be Fairly Valued.

Key valuation signals for SHSE:688338:

  • ROCE %: 5.45%
  • GF Value™: ¥30.49 vs. price of ¥29.13 (4.5% below fair value)
  • GF Score™: 86/100 with 5 warning signs
  • Industry Position: 141.2% above the Medical Devices & Instruments median

No single metric tells the full story. See the SHSE:688338 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Succeeder Technology Business Description

Address Innovation Road, No. 1, Xingchang Road, Block 1A, No. 27, Science and Technology Park, 3rd Floor, Building 1, Changping District, East District, East District, Beijing, CHN, 102200
Beijing Succeeder Technology Inc is engaged in production and sales of detection instruments, reagents and consumables in the field of in vitro diagnosis of thrombosis and hemostasis. The company develops, manufactures and sells in-vitro diagnostic products including coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers and platelet aggregation analyzers. Its product portfolio includes Fully Auto Coagulation Analyzer; Semi Auto Coagulation Analyzer; ESR Analyzer; Platelet Aggregation Analyzer; and Coagulation Reagents.
86GF Score

Get the complete analysis for SHSE:688338

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥29.13
Price
¥30.49
GF Value